Q1 Earnings Forecast for Neurogene Issued By Leerink Partnrs
Research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Neurogene in a report released on ...
Q1 Earnings Forecast for CorMedix Issued By Leerink Partnrs
Analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for CorMedix in a research note issued on Tuesday, March 25th. Leerink Partnrs analyst R. Ruiz forecasts that the company will post ...
Investor's Business Daily on MSN10h
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1
Novo Nordisk stock slipped 1.2% to 69.30. Novo Nordisk Is On A Licensing Spree. This is the second big weight-loss deal from Novo ...
Fintel on MSN18h
Leerink Partners Downgrades Equillium (EQ)
Fintel reports that on March 28, 2025, Leerink Partners downgraded their outlook for Equillium (NasdaqCM:EQ) from Outperform ...
Equillium downgraded to Market Perform from Outperform at Leerink
Leerink analyst Thomas Smith downgraded Equillium (EQ) to Market Perform from Outperform with a price target of $1, down from $3. The company ...
Newly public Beta Bionics reports sales surge; Dexcom hires CCO
Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former Masimo exec Jon Coleman joined Dexcom, and Sibionics’ CGM earned the CE mark.